References
- Abei H., Quitt J., Lauber E. Demethylierung in vivo und vitro von methixen. Naunyn-Schmiedebergs Archiv fur Pharmakologie Und Experimentelle Pathologie 1963; 244: 477–492
- Adedoyin A., Arrons L., Houston J. B. Dose-dependent pharmacokinetics of cimetidine in the rat. Xenobiotica 1987a; 17: 595–604
- Adedoyin A., Arrons L., Houston J. B. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat. Drug Metabolism and Disposition 1987b; 15: 127–132
- Anders M. W. Enhancement and inhibition of microsomal drug metabolism. Progress in Drug Research 1973; 17: 11–32
- Anders M. W., Mannering G. J. Inhibition of drug metabolism. I. Kinetics of the inhibition of the N-demethylation of ethylmorphine by 2-diethylaminoethyl 2,2-diphenylvalerate HCl (SKF 525-A) and related compounds. Molecular Pharmacology 1966; 2: 319–327
- Buening M. K., Franklin M. R. SKF 525-A inhibition, induction, and 452 nm complex formation. Drug Metabolism and Disposition 1976; 4: 244–255
- Black K. A., Virayotha V., Tephly T. R. Reduction of hepatic tetrahydrofolate and inhibition of exhalation of 14CO2 formed from [dimethylamino-14C] aminopyrine in nitros-oxide treated rats. Hepatology 1984; 4: 871–876
- Cooper J. R., Axelrod J., Brodie B. Inhibitory effect of B-diethylaminoethyl diphenyl-propylacetate on a variety of drug metabolic pathways in vitro. Journal of Pharmacology and Experimental Therapeutics 1954; 112: 55–63
- Desmond P. V., Patwardhan R., Parker R., Schenker S., Speeg K. V., Jr. Effects of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Sciences 1980; 26: 1261–1268
- Houston J. B., Lockwood G. F., Taylor G. Aminopyrine demethylation kinetics: Use of metabolic exhalation rates as an index of enhanced mixed-function oxidase activity in vivo. Drug Metabolism and Disposition 1981; 9: 449–455
- Kotake A. N., Schreider B. D., Latts J. R. The in vivo measurement of expired 14CO2 derived from the N-demethylation of aminopyrine as a reflection of the in vitro hepatic cytochrome P-450 drug metabolism activity in rats. Drug Metabolism and Disposition 1982; 10: 251–258
- Knodell R. G., Holtzman J. L., Crankshaw D. L., Stefle N. M., Stanely L. N. Drug metabolism by rat and human hepatic microsomes in response to interactions with H2-receptor antagonists. Gastroenterology 1982; 82: 84–88
- Lane E. A., Parashos I. Drug pharmacokinetics and the carbon dioxide breath test. Journal of Pharmacokinetics and Biopharmacology 1986; 14: 29–49
- Lauterburg B. H., Bircher J. Expiratory measurement of maximal aminopyrine demethylation in vivo: Effect of phenobarbital, partial hepatectomy, portacaval shunt and bile duct ligation in the rat. Journal of Pharmacology and Experimental Therapeutics 1976; 196: 501–509
- Loft S., Poulsen H. E. Prediction of xenobiotic metabolism by non-invasive methods. Pharmacology and Toxicology 1990; 67: 101–108
- Rhodes J. C., Hall S. T., Houston J. B. Inhibition of antipyrine metabolite formation in rats in vivo. Xenobiotica 1984; 14: 677–686
- Stitzel R. E., Anders M. W., Mannering G. J. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HCl (SKF 525-A) and its N-deethylated derivatives. Molecular Pharmacology 1966; 2: 335–340
- Speeg K. V., Jr., Patwardhan R. V., Avant G. R., Mitchell M. C., Schenker S. Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology 1982; 82: 89–96
- Shaw P. N., Tseti J., Warburton S., Adedoyin A., Houston J. B. Inhibition of antipyrine metabolite formation: Steady state studies with cimetidine and metyrapone in rats. Drug Metabolism and Disposition 1986; 14: 271–276
- Slusher L. B., Park S. S., Gelhoin H. V., Vessell E. S. Studies on the metabolism of aminopyrine, antipyrine and theophylline using monoclonal antibodies to cytochrome P-450 isozymes purified from rat liver. Biochemical Pharmacology 1987; 36: 2359–2367
- Testa B., Jenner P. Inhibitors of cytochrome P-450's and their mechanism of action. Drug Metabolism Reviews 1981; 12: 1–117
- Teunissen M. W. E., Kleinbloesem C. H., De Leede L. G. J., Breimer D. D. Influence of cimetidine on steady state concentrations and metabolite formation from antipyrine with a rectal osmotic minipump. European Journal of Clinical Pharmacology 1985; 28: 681–684
- Waydhas C., Weigl K., Sies H. The disposition of formaldehyde and formate arising from drug N-demethylations dependent on cytochrome P-450 in hepatocytes and in perfused rat liver. European Journal of Biochemistry 1978; 89: 143–150